VC

Vimal Chhaganlal Chandegra

Active Director Additional Director DIN 11043284
DIN 11043284 First appointment Apr 2025 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vimal Chhaganlal Chandegra

Data last updated:

Vimal Chhaganlal Chandegra is an Additional Director at Vhg Pharma Private Limited (since 2025). The company operates in Trading.

DIN 11043284
Primary Designation Additional Director
Industry Trading
First Appointment 03 Apr 2025
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vhg Pharma Private Limited U51909MH2022PTC383520
Additional Director03 Apr 20252022Active

Board colleagues of Vimal Chhaganlal Chandegra

NameDINCompanyDesignation
Sagar Chandrakant Pawar09620802Vhg Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vhg Pharma Private Limited
Premium access

Shareholding and investment profile for Vimal Chhaganlal Chandegra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vimal Chhaganlal Chandegra

Vimal Chhaganlal Chandegra currently holds 1 directorship: Vhg Pharma Private Limited (Additional Director, since 03 Apr 2025).

Vimal Chhaganlal Chandegra was first appointed on 03 Apr 2025 as Additional Director at Vhg Pharma Private Limited.

The current boards of Vimal Chhaganlal Chandegra's companies include Sagar Chandrakant Pawar (Vhg Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available